Skip to main content
Clinical Trials/NCT04515563
NCT04515563
Completed
Not Applicable

Effectiveness of Different Exercise Intensities and Frequencies of Walking Exercise on Improving Cognitive Function in Older Adults With Mild Cognitive Impairment: a Pilot Randomized Controlled Trial

The University of Hong Kong1 site in 1 country50 target enrollmentMarch 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
The University of Hong Kong
Enrollment
50
Locations
1
Primary Endpoint
Global cognition-Hong Kong Montreal Cognitive Assessment (HK-MoCA) score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The increasing prevalence of mild cognitive impairment (MCI) in our rapidly aging population prompts the need for devising effective interventions to prevent the onset of cognitive impairment and delay its progression to dementia. The benefits of aerobic exercise on the cognitive function in older adults with MCI are well-documented. However, exercise protocols and outcome measurement tools in the current literature are highly heterogeneous. It is therefore imperative to develop standard exercise prescription protocol for the MCI population or to examine the effectiveness of the existing, well-established exercise guidelines. The World Health Organization (WHO) recommends adults (18 - 64 years of age) and older adults (65 years and older) to perform 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity aerobic physical activity per week to improve cardiorespiratory and muscular fitness, bone health, and reduce the risk of non-communicable diseases and depression. Nonetheless, few studies have determined the effectiveness of the WHO Global Recommendations on Physical Activity for Health guideline in improving cognitive function in older adults with MCI. This study thus aims to evaluate the effectiveness of the WHO Physical Activity Recommendations in improving cognitive function in older adults with MCI. In 2017, the American Academy of Neurology (AAN) updated the Practice Guideline for Mild Cognitive Impairment, in which they recommended patients diagnosed with MCI to perform exercise at least twice a week for at least 6 months to gain cognitive benefits. This recommendation was based on two class-II studies, in which a 6-month twice-a-week 90-minute multicomponent exercise program helped maintain global cognition, and selective attention improved significantly following a 6-month twice-a-week 60-minute multicomponent exercise program. While they provided pivotal insights into clinical practice, there were several limitations for these two studies. For instance, in the study conducted by Nagamatsu et al., only female subjects were recruited, and therefore lead to low generalizability. These two studies focused on multi-component exercise intervention which included resistance training, aerobic training, and balance training, and the duration of each component was short (around 20 - 30 minutes). Studies that focus on single exercise modality with longer session duration are warranted to unveil the efficacy of a certain exercise modality in improving cognitive function. In this study, we will evaluate the effectiveness of aerobic exercise on improving cognitive function in older adults with MCI. We intend to follow the WHO Recommendations, focusing on evaluating the effect of different exercise intensities (moderate versus vigorous) and frequencies (once versus thrice per week) of aerobic exercise on improving the cognitive function in older adults with mild cognitive impairment. In particular, the AAN also suggested that physical activity of at least twice a week is necessary to produce cognitive benefits. We, therefore, aim to investigate whether one session per week would also suffice to improve the cognitive function in older adults with MCI.

Aims: To examine the effectiveness of 12-week WHO Global Recommendations on Physical Activity for Health in practice in improving the cognitive function in older adults with MCI.

Registry
clinicaltrials.gov
Start Date
March 1, 2020
End Date
September 1, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Parco M. Siu, PhD

Associate Professor & Division Head

The University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Older adults aged ≥ 50 years old;
  • Ethnic Chinese;
  • Diagnosed with mild cognitive impairment (MCI) under the Mayo Clinic criteria \[8-10\]: 1). Subjective complaint about a decline in cognitive function; 2). Total score in the Hong Kong version of the Montreal Cognitive Assessment is below the 7th percentile of the age- and education-corrected normative data of Hong Kong; 3). The decline in cognitive function does not impair daily functioning, as revealed by getting ≥ 2 marks in every item on the Chinese Lawton Instrumental Activities of Daily Living Scale (4-point Scale).

Exclusion Criteria

  • Diagnosis of dementia/Alzheimer's disease, or currently using antidementia medication;
  • Incapable of participating in physical exercise with major confounding conditions that are known to affect mobility. Specifically designed questionnaires will be used to screen for exclusion criteria including 1). Cannot walk without assistive device; 2). Any serious somatic condition that prevents walking exercise participation.
  • History of major diseases e.g. cancer, cardio-/cerebrovascular, neurodegenerative and renal diseases;
  • Diagnosis of psychiatric diseases, or currently using psychiatric medication.

Outcomes

Primary Outcomes

Global cognition-Hong Kong Montreal Cognitive Assessment (HK-MoCA) score

Time Frame: 3-month follow-up

Age- and education-corrected Hong Kong Montreal Cognitive Assessment (HK-MoCA). The HK-MoCA is a validated assessment for cognitive screening that takes into account different domains of cognition, which will enable the researchers to achieve a better understanding of the global cognitive profile of the individual. Higher score indicates better global cognitive performance.

Secondary Outcomes

  • Objective cognitive score(3-month follow-up)
  • Bone mineral density(3-month follow-up)
  • Working memory-Digit Span test(3-month follow-up)
  • Balance performance(3-month follow-up)
  • VO2max(3-month follow-up)
  • Working memory-Verbal Fluency Test(3-month follow-up)
  • Executive function-Trail Making test(3-month follow-up)
  • Subjective cognitive report(3-month follow-up)
  • Remission rate-Chinese Abbreviated Mild Cognitive Impairment Test (CAMCI)(3-month follow-up)
  • Remission rate-Hong Kong Montreal Cognitive Assessment (HK-MoCA)(3-month follow-up)
  • Body fat mass(3-month follow-up)
  • Quality of Life-12-item Short Form Survey (SF-12)(3-month follow-up)
  • Executive function-Stroop test(3-month follow-up)
  • Lean mass(3-month follow-up)
  • Habitual sleep(3-month follow-up)
  • Mental health(3-month follow-up)
  • Anxiety level(3-month follow-up)
  • Depression level(3-month follow-up)
  • Physical activity(3-month follow-up)

Study Sites (1)

Loading locations...

Similar Trials